<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(1)</volume><submitter>Cohen R</submitter><funding>Association Clinique Thérapeutique Infantile du Val de Marne</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>In autumn 2022, the epidemics due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), respiratory syncytial virus (RSV), and influenza overlapped, and these diseases can present with the same symptomatology. The use of a triple antigen test (SARS-CoV-2 + influenza A/B + RSV) seems crucial for accurate viral diagnosis in the context of implementing long-acting monoclonal antibody vaccination against RSV in the upcoming RSV season.&lt;h4>Methods&lt;/h4>We assessed the usefulness of the triple test in real life in this prospective study performed from October 2022 to May 2023 and involving 116 pediatricians (2 emergency department pediatricians and 114 ambulatory pediatricians). Children &lt;15 years old with flu-like illness (with fever), bronchiolitis (dyspnea ± wheez</pubmed_abstract><journal>Open forum infectious diseases</journal><pagination>ofad617</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10764097</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Use of Rapid Antigen Triple Test Nasal Swabs (COVID-VIRO ALL-IN TRIPLEX: Severe Acute Respiratory Syndrome Coronavirus 2, Respiratory Syncytial Virus, and Influenza) in Children With Respiratory Symptoms: A Real-life Prospective Study.</pubmed_title><pmcid>PMC10764097</pmcid><pubmed_authors>de Lays CT</pubmed_authors><pubmed_authors>Bechet S</pubmed_authors><pubmed_authors>Haas H</pubmed_authors><pubmed_authors>Cohen R</pubmed_authors><pubmed_authors>Romain C</pubmed_authors><pubmed_authors>de Pontual L</pubmed_authors><pubmed_authors>Levy C</pubmed_authors><pubmed_authors>Romain O</pubmed_authors><pubmed_authors>Guiheneuf C</pubmed_authors><pubmed_authors>Wollner A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Use of Rapid Antigen Triple Test Nasal Swabs (COVID-VIRO ALL-IN TRIPLEX: Severe Acute Respiratory Syndrome Coronavirus 2, Respiratory Syncytial Virus, and Influenza) in Children With Respiratory Symptoms: A Real-life Prospective Study.</name><description>&lt;h4>Background&lt;/h4>In autumn 2022, the epidemics due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), respiratory syncytial virus (RSV), and influenza overlapped, and these diseases can present with the same symptomatology. The use of a triple antigen test (SARS-CoV-2 + influenza A/B + RSV) seems crucial for accurate viral diagnosis in the context of implementing long-acting monoclonal antibody vaccination against RSV in the upcoming RSV season.&lt;h4>Methods&lt;/h4>We assessed the usefulness of the triple test in real life in this prospective study performed from October 2022 to May 2023 and involving 116 pediatricians (2 emergency department pediatricians and 114 ambulatory pediatricians). Children &lt;15 years old with flu-like illness (with fever), bronchiolitis (dyspnea ± wheez</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jan</publication><modification>2026-06-22T03:15:03.521Z</modification><creation>2025-04-05T12:46:26.9Z</creation></dates><accession>S-EPMC10764097</accession><cross_references><pubmed>38173847</pubmed><doi>10.1093/ofid/ofad617</doi></cross_references></HashMap>